Trial intelligence / Profile preview

Oxytocin and Fear Processing in Naturalistic Contexts

NCT05892939Completed

Sponsor
University of Electronic Science and Technology of China
Start
May 2023
Primary completion
Apr 2024
Countries
1
01

Overview

Randomised, double-blind trial of oxytocin nasal spray in anxiety disorders (2 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoint: Blood-Oxygen-Level-Dependent activity. Started May 2023; status: completed.

02

Drugs

oxytocin nasal spray
03

Conditions

anxiety disorders

Beyond the preview

Go deeper on NCT05892939.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05892939.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call